Akero Therapeutics, Inc. (AKRO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Akero Therapeutics, Inc., with annual and quarterly history.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -7.41x | -8.09x | -19.07x | -7.31x | -10.25x | -7.65x |
| P/B Ratio | 2.49x | 2.29x | 6.54x | 4.36x | 3.14x | 2.60x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 19.38x | 29.27x | 18.61x | 7.70x | 20.70x | 14.73x |
| Quick Ratio | 19.38x | 29.27x | 18.61x | 7.70x | 20.70x | 14.73x |
| Leverage | ||||||
| Debt/Equity | 0.05x | 0.05x | 0.03x | 0.01x | 0.01x | 0.00x |
YoY = year-over-year change. Source: FMP..